To view more details, including parent strains and references, click on the corresponding dictyBase ID.
| Strain ID |
Strain Descriptor |
Associated gene(s) |
Phenotypes |
| DBS0266721 | Dd5P4-/ [act15]: Hs-OCRL(D422A) | Dd5P4 | decreased phagocytosis |
| DBS0237041 | VatMpr | vatM | aberrant intracellular pH level, decreased growth rate, decreased phagocytosis, increased localization of protein to the cytoplasm |
| DBS0237236 | [AS]: [tet]: trrA | trrA | abolished aggregation, decreased growth rate, delayed development |
| DBS0237228 | [AS]GP138A/ [AS]GP138B | cfrA, cfrB | decreased sexual fusion |
| DBS0304456 | [AS]alrA/ gcsA- | alrA, gcsA | cell cycle arrest, decreased growth rate in suspension |
| DBS0237273 | [AS]calA | calA | abolished cytokinesis |
| DBS0237224 | [AS]cmfA | cmfA | abolished aggregation |
| DBS0237225 | [AS]cupB | cupB | abolished aggregation |
| DBS0237226 | [AS]dia1 | dia1 | decreased gene expression, precocious aggregation |
| DBS0238235 | [AS]dutA | dutA | wild type |
| DBS0237229 | [AS]gpaA | gpaA | wild type |
| HPF414 | [AS]hspA | hspA | aberrant fruiting body morphology, decreased growth rate |
| DBS0238749 | [AS]hspA/ snfA | hspA, snfA | wild type |
| DBS0252819 | [AS]hssA | hssA | wild type |
| DBS0237230 | [AS]ino1 | ino1 | abolished growth |
| DBS0236725 | [AS]patA | patA | decreased growth rate under Ca2+ stress |
| DBS0237504 | [AS]pikE | pikE | aberrant stalk morphogenesis, decreased growth rate |
| DBS0237232 | [AS]proA | proA | wild type |
| DBS0236827 | [AS]proA/ proB- | proA, proB | aberrant cytokinesis, abolished growth, decreased cell motility, development arrests at slug stage, increased basal F-actin level |
| DBS0238036 | [AS]proA/ proB-/ [act15]: proA | proA, proB | wild type |
| DBS0238037 | [AS]proA/ proB-/ [act15]: proB | proA, proB | wild type |
| DBS0236851 | [AS]rapA | rapA | aberrant osmosensory signaling pathway, aberrant response to hyperosmotic stress, decreased phagocytosis, decreased pinocytosis, increased basal phosphorylated actin level, inviable |
| DBS0236904 | [AS]rps4 | mrps4 | aberrant fruiting body morphology, delayed aggregation |
| DBS0238748 | [AS]snfA | snfA | aberrant mitochondrion organization and biogenesis, decreased fruiting body size, decreased intracellular ATP level, decreased number of mitochondria, increased growth rate |
| DBS0304498 | [AS]sslA1 | sslA1 | decreased fruiting body size |
| DBS0237235 | [AS]tcp1 | tcp1 | aberrant fruiting body morphology, decreased growth rate, development arrests at mound stage |
| DBS0266892 | [KD]gtaC | gtaC | abolished stalk cell differentiation |
| DBS0266893 | [KD]gtaC/ [act15]: GFP: gtaC | gtaC | wild type |
| DBS0302601 | [OE]: disgorgin(Q551A)/ disgorgin- | DDB_G0280955 | aberrant contractile vacuole organization and biogenesis |
| DBS0302600 | [OE]: disgorgin(R515A)/ disgorgin- | DDB_G0280955 | aberrant contractile vacuole organization and biogenesis |
| DBS0235409 | [RNAi]cnbA | cnbA | aberrant stalk cell differentiation, decreased gene expression, decreased stalk length, multiple tips in culminant |
| DBS0237295 | [RNAi]fimA | fimA | wild type |
| DBS0252820 | [RNAi]hssA | hssA | wild type |
| DBS0237310 | [RNAi]lipA | lipA | wild type |
| DBS0237296 | [RNAi]pks16 | pks16 | wild type |
| DBS0237311 | [RNAi]racF2 | racF2 | abolished growth in suspension |
| DBS0238734 | [RNAi]sdhA | sdhA | abolished aggregation, decreased phototaxis |
| DBS0304564 | [RNAi]sun1 | sun1 | aberrant nucleus morphology, increased cell size |
| DBS0237818 | [RNAi]wipA | wipA | decreased F-actin polymerization at the leading edge, decreased chemotaxis to cAMP, decreased filopodium formation, delayed pseudopod formation |
| DBS0238108 | [act15]: FLAG: ppp4C(H113Q) | ppp4c | delayed development, development arrests at mound stage |
| DBS0237132 | [act15]: GFP: racH(T18N) | racH | aberrant cell morphology, aberrant cytokinesis |
| DBS0238393 | [act15]: GFP: rapA(G12V) | rapA | increased cell-substrate adhesion |
| DBS0238394 | [act15]: GFP: rapA(S17N) | rapA | decreased cell-substrate adhesion |
| DBS0304563 | [act15]: GFP: sun1(283-905) | sun1 | aberrant centrosome localization, aberrant nucleus morphology, aberrant perinuclear space, aberrant sister chromosome segregation, decreased localization of a protein to the nuclear envelope, increased cell size, increased number of centrosomes |
| DBS0237227 | [act15]: [AS]dia2 | dia2 | aberrant cAMP signaling during aggregation, abolished aggregation, decreased extracellular cAMP level |
| DBS0238088 | [act15]: atg1(K36A) | atg1 | aberrant cellular response to nitrogen starvation, abolished aggregation, abolished macroautophagy, increased number of autophagosomes |
| DBS0252740 | [act15]: carA(I104D) | carA-1, carA-2 | aberrant cAMP wave formation, decreased MAP kinase activation, delayed aggregation, increased cAMP binding |
| DBS0252744 | [act15]: carA(I104E) | carA-1, carA-2 | aberrant cAMP wave formation, delayed aggregation, increased cAMP binding |
| DBS0252747 | [act15]: carA(I104H) | carA-1, carA-2 | abolished cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0252749 | [act15]: carA(I104K) | carA-1, carA-2 | abolished aggregation, abolished cAMP wave formation, decreased MAP kinase activation, increased cAMP binding |
| DBS0252746 | [act15]: carA(I104N) | carA-1, carA-2 | abolished cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0252745 | [act15]: carA(I104Q) | carA-1, carA-2 | abolished cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0252750 | [act15]: carA(I104R) | carA-1, carA-2 | abolished cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0252748 | [act15]: carA(I104Y) | carA-1, carA-2 | aberrant cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0237098 | [act15]: cdk5(D144N) | cdk5 | decreased extracellular counting factor component(s) level, decreased growth rate, decreased phagocytosis, decreased pinocytosis, decreased sporulation, delayed aggregation, increased aggregate size, increased extracellular counting factor component(s) level, increased intracellular counting factor component(s) level |
| DBS0266839 | [act15]: myc: ptpΔ(3C649S) | ptpC | aberrant localization of protein to the nucleus, increased protein tyrosine phosphorylation |
| DBS0266838 | [act15]: myc: ptpC(C649S) | ptpC | aberrant localization of protein to the nucleus, increased protein tyrosine phosphorylation |
| DBS0238396 | [act15]: myc: rapA(G12V) | rapA | decreased cell motility, delayed aggregation, increased cell-substrate adhesion |
| DBS0238397 | [act15]: myc: rapA(S17N) | rapA | decreased cell-substrate adhesion |
| DBS0237183 | [act15]: pakA(K394A) | pakA | delayed development, development arrests at mound stage |
| DBS0237184 | [act15]: pakA[CA] | pakA | abolished aggregation |
| DBS0237219 | [act6]: ptpC(C649S) | ptpC | decreased growth rate, increased aggregate size |
| DBS0237252 | [gpaA]: gpaA(G45V) | gpaA | delayed development |
| DBS0237253 | [gpaA]: gpaA(Q206L) | gpaA | increased basal disc size |
| DBS0238351 | [tet]: [RNAi]cinC | cinC | decreased growth rate, decreased translation, precocious aggregation |
| DBS0237318 | [tet]: pten | pten | decreased cell motility |
| DBS0237622 | [tet]: rapA(S17N)/ [act15]: gbpD | gbpD, rapA | aberrant cell morphology, increased cell polarity, increased cell-substrate adhesion |
| DBS0304911 | [tre]: paxB | paxB | aberrant chemotaxis to folate, aberrant endocytosis, abolished sporulation, decreased cell motility, decreased cell-substrate adhesion, development arrests at mound stage, increased cell-cell adhesion |
| DBS0237786 | acrA-/ [act15]: acgA(1-401) | acgA, acrA | decreased gene expression, decreased prespore cell differentiation, decreased sporulation |
| DBS0238093 | atg1-/ [act15]: atg1(P138S) | atg1 | abolished aggregation |
| DBS0235570 | carB- | carB | development arrests at mound stage |
| DBS0237568 | ctxA-/ [RNAi]enlA | ctxA, enlA | wild type |
| DBS0304913 | gbpC-/ [act15]: gbpC(K342N) | gbpC | decreased chemotaxis to cAMP |
| DBS0304914 | gbpC-/ [act15]: gbpC(K905W) | gbpC | decreased chemotaxis to cAMP |
| DBS0237190 | gdt1-/ [act15]: pkaR(G135E/ G261A) | gdt1, pkaR | abolished aggregation, increased gene expression |
| DBS0236092 | gpaA-/ [gpaA]: gpaA(G45V) | gpaA | delayed development |
| DBS0236093 | gpaA-/ [gpaA]: gpaA(Q206L) | gpaA | increased basal disc size |
| DBS0237564 | mhcA-/ [act15]: GFP: ctxA/ [RNAi]enlA | ctxA, enlA, mhcA | aberrant cytokinesis, contractile ring contraction |
| DBS0238399 | mhcA-/ [act15]: rapA(G12V) | mhcA, rapA | aberrant myosin II organization, increased basal F-actin level, increased cell polarity |
| DBS0304881 | mrps4- | mrps4 | delayed aggregation |
| DBS0304882 | mtDNA- | DidioMp05, DidioMp21, DidioMp26, DidioMp27, DidioMp30, DidioMp35, DidioMp36, ai2a, ai2b, ai3, ai4, atp1, atp6, atp9, cox1/ 2, cox3, cytB, mrpl11, mrpl14, mrpl16, mrpl2, mrpl6, mrps12, mrps13, mrps14, mrps19, mrps2, mrps4, mrps7, mrps8, nad1, nad11, nad2, nad3, nad4, nad4L, nad5, nad6, nad7, nad9, rnlA | abolished aggregation, abolished growth |
| DBS0236583 | myoB-/ [AS]myoD | myoB, myoD | aberrant aggregation, decreased aggregate size, decreased cell motility, decreased growth rate, decreased phagocytosis, decreased pinocytosis |
| DBS0236584 | myoB-/ [AS]myoD/ [KD]myoC | myoB, myoC, myoD | aberrant aggregation, decreased aggregate size, decreased cell motility, decreased growth rate, decreased phagocytosis, decreased pinocytosis, increased number of pinosomes, small pinosomes |
| HM1060 | nsfA(A1847G, A1939T, T1977C, T2005G, A2025T, A2366T) | nsfA | abolished cell motility, decreased F-actin polymerization at the leading edge, decreased phagocytosis, decreased rate of endocytosis |
| HM1067 | nsfA(A1854T, T1984A, C2131A, A2398T, T2574A) | nsfA | abolished cell motility, decreased F-actin polymerization at the leading edge, decreased cell motility, decreased rate of endocytosis, increased phagocytosis |
| DBS0236789 | pkgB-/ [act15]: pkgB(K182M) | pkgB | development arrests at mound stage |
| DBS0302357 | psrA-/ [act15]: gskA(K84M/ K85M) | gskA, psrA | decreased culmination, decreased gene expression, delayed development |
| DBS0236884 | rckA-/ [act15]: myc: rckA(K867A) | rckA | decreased chemotaxis rate, development arrests at mound stage |
| HM1163 | sec1(M213K, E258G, M427V, K527I, T541N, F558S, N581D) | sec1 | abolished cell motility |
| DBS0238395 | talA-/ [act15]: rapA(G12V) | rapA, talA | increased cell-substrate adhesion |
| DBS0302382 | tsuA-/ [unk]: tsuA(K34R): YFP | tsuA | decreased aggregate size, decreased fruiting body size |
| DBS0237051 | wasA1- | wasA | aberrant F-actin organization, decreased cell motility, delayed development |
| DBS0237052 | wasA1-/ [tet]: YFP: wasA2 | wasA | aberrant F-actin organization, abolished aggregation, abolished chemotaxis, decreased F-actin polymerization |
| DBS0237811 | wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA(Y33A/ W39A/ F90A/ F91A) | wasA | decreased F-actin polymerization, decreased F-actin polymerization at the leading edge |
| DBS0237820 | wasA1-/ [tet]: YFP: wasA2/ [act15]: wipA | wasA, wipA | abolished chemotaxis |
